Skip to main content

Advertisement

Log in

Optical coherence tomography angiography for detection of macular neovascularization associated with atrophy in age-related macular degeneration

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the ability of optical coherence tomography angiography (OCTA) to detect macular neovascularization (MNV) in eyes with atrophy compared with fluorescein angiography (FA), indocyanine green angiography (ICGA), and optical coherence tomography (OCT).

Methods

In this prospective study, eyes with MNV and atrophy (termed macular atrophy or MA) secondary to age-related macular degeneration (AMD), and AMD eyes with geographic atrophy (GA) without MNV underwent multimodal imaging with FA, ICGA, structural OCT, and OCTA. The presence of MNV was determined using all imaging modalities by senior retina specialists and was considered the gold standard reference. Each individual imaging modality was then evaluated independently by two expert readers for the presence of MNV in a masked fashion. Morphologic characteristics of the MNV were evaluated on the custom OCTA slab.

Results

Twenty-one patients with MA+MNV and 21 with GA only were enrolled. Manual segmentation on OCTA allowed detection of the MNV in 95.2% of eyes with MA+MNV and in 4.7% of eyes with GA, showing high specificity (95.2%) and sensitivity (95.2%). FA, ICGA, and OCT detected MNV in 57.1%, 52.3%, and 66.7% of eyes with MA+MNV and in 14.2%, 9.5%, and 42.8% with GA. Sensitivity and specificity were 85.7% and 57.1% for FA, 90.5% and 52.4% for ICGA, and 66.7% and 57.1% for OCT.

Conclusions

OCTA appears to be superior to other imaging modalities for identification of MNV in eyes with macular atrophy. OCTA should be considered as part of the multimodal imaging evaluation of eyes with atrophy, particularly in the context of clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

All data relevant to the study are included in the article or uploaded as supplementary information.

References

  1. Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K et al (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844–851

    Article  Google Scholar 

  2. Holz FG, Strauss EC, Schmitz-Valckenberg S, van Lookeren CM (2014) Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology 121:1079–1091

    Article  Google Scholar 

  3. Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC et al (2018) Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3. Ophthalmology 125:537–548

    Article  Google Scholar 

  4. Sarks SH (1976) Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol 60:324–341

    Article  CAS  Google Scholar 

  5. Green WR, Key SN 3rd (1977) Senile macular degeneration: a histopathologic study. Trans Am Ophthalmol Soc 75:180–254

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Green WR, Enger C (1993) Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman lecture. Ophthalmology 100:1519–1535

    Article  CAS  Google Scholar 

  7. Dansingani KK, Freund KB (2015) Optical coherence tomography angiography reveals mature, tangled vascular networks in eyes with neovascular age-related macular degeneration showing resistance to geographic atrophy. Ophthalmic Surg Lasers Imaging Retina 46:907–912

    Article  Google Scholar 

  8. Christenbury JG, Phasukkijwatana N, Gilani F, Freund KB, Sadda S, Sarraf D (2018) Progression of macular atrophy in eyes with type 1 neo-vascularization and age-related macular degeneration receiving long-term intravitreal anti-vascular endothelial growth factor therapy: an optical coherence tomographic angiography analysis. Retina 38:1276–1288

    Article  CAS  Google Scholar 

  9. Sunness JS, Gonzalez-Baron J, Bressler NM, Hawkins B, Applegate CA (1999) The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration. Ophthalmology 106:910–919

    Article  CAS  Google Scholar 

  10. Macular Photocoagulation Study Group (1993) Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 111:1189–1199

    Article  Google Scholar 

  11. Macular Photocoagulation Study Group (1997) Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol 115:741–747

    Article  Google Scholar 

  12. Querques G, Rosenfeld PJ, Cavallero E, Borrelli E, Corvi F, Querques L et al (2014) Treatment of dry age-related macular degeneration. Ophthalmic Res 52:107–115

    Article  CAS  Google Scholar 

  13. Liao DS, Grossi FV, El Mehdi D, Gerber MR, Brown DM, Heier JS et al (2020) Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial. Ophthalmology 127:186–195

    Article  Google Scholar 

  14. Schmidt-Erfurth U, Chong V, Loewenstein A, Larsen M, Souied E, Schlingemann R et al (2014) Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol 98:1144–1167

    Article  Google Scholar 

  15. American Academy of Ophthalmology. (2015) Age-related macular degeneration preferred practice pattern guidelines: updated 2015. Available at: http://www.aao.org/ppp. Accessed December 2017

  16. Spaide RF, Klancnik JM Jr, Cooney MJ (2015) Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol 133:45–50

    Article  Google Scholar 

  17. Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G (2018) Optical coherence tomography angiography. Prog Retin Eye Res 64:1–55

    Article  Google Scholar 

  18. de Carlo TE, Bonini Filho MA, Chin AT, Adhi M, Ferrara D, Baumal CR et al (2015) Spectral-domain optical coherence tomography angiography of choroidal neovascularization. Ophthalmology 122:1228–1238

    Article  Google Scholar 

  19. Capuano V, Miere A, Querques L, Sacconi R, Carnevali A, Amoroso F et al (2017) Treatment-naïve quiescent choroidal neovascularization in geographic atrophy secondary to nonexudative age-related macular degeneration. Am J Ophthalmol 182:45–55

    Article  Google Scholar 

  20. Wu Z, Luu CD, Ayton LN, Goh JK, Lucci LM (2014) Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration. Ophthalmology 121:2415–2422

    Article  Google Scholar 

  21. Spaide RF, Fujimoto JG, Waheed NK (2015) Image artifacts in optical coherence tomography angiography. Retina 35:2163–2180

    Article  Google Scholar 

  22. Wilde C, Patel M, Lakshmanan A, Amankwah R, Dhar-Munshi S, Amoaku W, Medscape (2015) The diagnostic accuracy of spectral-domain optical coherence tomography for neovascular age-related macular degeneration: a comparison with fundus fluorescein angiography. Eye (Lond) 29:602–609

    Article  CAS  Google Scholar 

  23. Nesper PL, Lutty GA, Fawzi AA (2018) Residual choroidal vessels in atrophy can masquerade as choroidal neovascularization on optical coherence tomography angiography: introducing a clinical and software approach. Retina 38:1289–1300

    Article  Google Scholar 

  24. Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G et al (2019) Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group. Ophthalmology. https://doi.org/10.1016/j.ophtha.2019.11.004

  25. Novais EA, Baumal CR, Sarraf D, Freund KB, Duker JS (2016) Multimodal imaging in retinal disease: a consensus definition. Ophthalmic Surg Lasers Imaging Retina 47:201–205

    Article  Google Scholar 

  26. Perrott-Reynolds R, Cann R, Cronbach N, Neo YN, Ho V, McNally O, Madi HA, Cochran C, Chakravarthy U (2019) The diagnostic accuracy of OCT angiography in naive and treated neovascular age-related macular degeneration: a review. Eye (Lond) 33:274–282

    Article  Google Scholar 

  27. Bagchi A, Schwartz R, Hykin P, Sivaprasad S (2019) Diagnostic algorithm utilising multimodal imaging including optical coherence tomography angiography for the detection of myopic choroidal neovascularisation. Eye (Lond) 33:1111–1118

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

FC: conception and design, acquisition of data, analysis and interpretation of data, drafting the article, and final approval of the manuscript. MC: conception and design, acquisition of data drafting the article, and final approval of the manuscript. AI and LP acquisition of data, revising the article critically for important intellectual content, and final approval of the manuscript. SRS: analysis and interpretation of data, revising the manuscript critically for important intellectual content, and final approval. GS analysis and interpretation of data, acquisition of data, revising the article critically for important intellectual content, and final approval.

Corresponding author

Correspondence to Federico Corvi.

Ethics declarations

Conflict of interest

Disclosure of potential conflicts of interest: F.Corvi, M.Cozzi and L.Pace declare no conflict of interest. A. Invernizzi: Allergan (financial support), Novartis (consultant), and Bayer (consultant). S.R. Sadda: Allergan (consultant, financial support), Carl Zeiss Meditec (financial support), Genentech (consultant, financial support), Amgen (consultant), Novartis (consultant), Optos (consultant, financial support), Centervue (consultant), Heidelberg (consultant), Regeneron (financial support), and Oxurion (consultant). G. Staurenghi: Heidelberg Engineering (consultant), Quantel Medical (consultant), Centervue (consultant), Carl Zeiss Meditec (consultant), Alcon (consultant), Allergan (consultant), Bayer (consultant), Boheringer (consultant), Genentech (consultant), GSK (consultant), Novartis (consultant), and Roche (consultant), and has received grant support from Optos (financial support), Optovue (financial support), and Centervue (financial support).

Ethics approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Each of the coauthors has seen and agrees with each of the changes made to this manuscript in the revision and to the way his or her name is listed.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Corvi, F., Cozzi, M., Invernizzi, A. et al. Optical coherence tomography angiography for detection of macular neovascularization associated with atrophy in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 259, 291–299 (2021). https://doi.org/10.1007/s00417-020-04821-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-020-04821-6

Keywords

Navigation